Skip to main content
Premium Trial:

Request an Annual Quote

Aclara and Stanford Extend eTag Contract

NEW YORK, June 18 -- Aclara BioSciences announced today the extension of a services and supply agreement with Stanford University for use in a new proteomics center.

 

The Mountain View, Calif.-based company will supply the Stanford University Medical Center with access to its eTag assay system technology, custom services, reagents, software, and support. The university will use the system for proteomics studies in the area of autoimmune disease.

 

Financial details were not disclosed.

 

Using funding from a seven-year, $14.6 million contract from the National Heart Lung and Blood Institute, Stanford's Center for Clinical Immunology will establish a proteomics center to study autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.

 

ACLARA's eTag technology is used in the analysis of genes and proteins.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.